PD-1/PD-L1 can combine to activate the PD-1/PD-L1 signaling pathway, thereby inhibiting the immune activity of T cells, causing tumor immune escape, leading to tumor occurrence and development (Chae et al., 2018). Here, PDCD1 is linked to neoplasm.